| 2002 |
Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. March 2002;112(4):281-289. |
77 |
74 |
| 1998 |
Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. May 15, 1998;128(10):793-800. |
29 |
21 |
| 2020 |
Langsetmo L, Burghardt AJ, Schousboe JT, Cawthon PM, Cauley JA, Lane NE, Orwoll ES, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Group. Objective measures of moderate to vigorous physical activity are associated with higher distal limb bone strength among elderly men. Bone. March 2020;132:115198. |
2 |
2 |
| 2005 |
Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, McGowan J, Phipps K, Sherman S, Stefanick ML, Stone K. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study: a large observational study of the determinants of fracture in older men. Contemp Clin Trials. October 2005;26(5):569-585. |
29 |
10 |
| 1999 |
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR; Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA. August 18, 1999;282(7):637-645. |
91 |
68 |
| 2006 |
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA. December 27, 2006;296(24):2927-2938. |
63 |
55 |
| 2011 |
Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM; Study of Osteoporotic Fractures (SOF); Osteoporotic Fractures in Men (MrOS); Health, Aging, and Body Composition (Health ABC) Research Groups. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. June 1, 2011;305(21):2184-2192. |
47 |
40 |
| 1995 |
Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES, Nevitt MC, Fox KM, Cummings SR. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res. November 1995;10(11):1778-1787. |
29 |
22 |
| 2001 |
Beck TJ, Oreskovic TL, Stone KL, Ruff CB, Ensrud K, Nevitt MC, Genant HK, Cummings SR. Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res. June 2001;16(6):1108-1119. |
19 |
16 |
| 2003 |
Stone KL, Seeley DG, Lui L-Y, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR; The Study of Osteoporotic Fractures research group. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res. November 2003;18(11):1947-1954. |
100 |
95 |
| 2005 |
Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK, Black DM, Ensrud KE; Fracture Intervention Trial Research Group. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. July 2005;20(7):1216-1222. |
18 |
17 |
| 2009 |
Orwoll ES, Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM; Osteoporotic Fractures in Men (MrOS) Study Group. Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res. March 2009;24(3):475-483. |
48 |
40 |
| 2011 |
Sheu Y, Zmuda JM, Boudreau RM, Petit MA, Ensrud KE, Bauer DC, Gordon CL, Orwoll ES, Cauley JA; Osteoporotic Fractures in Men (MrOS) Research Group. Bone strength measured by peripheral quantitative computed tomography and the risk of nonvertebral fractures: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res. January 2011;26(1):63-71. |
21 |
20 |
| 2012 |
Wang X, Sanyal A, Cawthon PM, Palermo L, Jekir M, Christensen J, Ensrud KE, Cummings SR, Orwoll E, Black DM, Keaveny TM; Osteoporotic Fractures in Men (MrOS) Research Group. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res. April 2012;27(4):808-816. |
28 |
23 |
| 2018 |
Langsetmo L, Peters KW, Burghardt AJ, Ensrud KE, Fink HA, Cawthon PM, Cauley JA, Schousboe JT, Barrett-Connor E, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Study Research Group. Volumetric bone mineral density and failure load of distal limbs predict incident clinical fracture independent of FRAX and clinical risk factors among older men. J Bone Miner Res. July 2018;33(7):1302-1311. |
19 |
15 |
| 2020 |
Kim KM, Lui L, Cauley JA, Ensrud KE, Orwoll ES, Schousboe JT, Cummings SR; Osteoporotic Fractures in Men (MrOS) Study Research Group. Red cell distribution width is a risk factor for hip fracture in elderly men without anemia. J Bone Miner Res. May 2020;35(5):869-874. |
2 |
1 |
| 2021 |
Schousboe JT, Ensrud KE. Opportunistic osteoporosis screening using low‐dose computed tomography (LDCT): promising strategy, but challenges remain. J Bone Miner Res. March 2021;36(3):425-426. |
0 |
0 |
| 2021 |
Ensrud KE, Schousboe JT, Kats AM, Vo TN, Taylor BC, Cawthon PM, Cauley JA, Lane NE, Hoffman AR, Langsetmo L; Osteoporotic Fractures in Men (MrOS) Research Group. Height loss in old age and fracture risk among men in late life: a prospective cohort study. J Bone Miner Res. June 2021;36(6):1069-1076. |
1 |
1 |
| 2021 |
Kim KM, Lui L-Y, Cauley JA, Ensrud KE, Orwoll ES, Schousboe JT, Cummings SR; Osteoporotic Fractures in Men (MrOS) Study Research Group. Response to “Red cell distribution width is a risk factor for hip fracture in elderly men without anemia”. J Bone Miner Res. June 2021;36(6):1203-1203. |
0 |
0 |
| 2021 |
Harvey NC, Orwoll E, Kwok T, Karlsson MK, Rosengren BE, Ribom E, Cauley JA, Cawthon PM, Ensrud K, Liu E, Cruz-Jentoft AJ, Fielding RA, Cooper C, Kanis JA, Lorentzon M, Ohlsson C, Mellström D, Johansson H, McCloskey E. Sarcopenia definitions as predictors of fracture risk independent of FRAX®, falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: a meta-analysis. J Bone Miner Res. July 2021;36(7):1235-1244. |
5 |
4 |
| 2022 |
Cawthon PM, Peters KE, Cummings SR, Orwoll ES, Hoffman AR, Ensrud KE, Cauley JA, Evans WJ; Osteoporotic Fractures in Men (MrOS) Study Research Group. Association between muscle mass determined by D₃-creatine dilution and incident fractures in a prospective cohort study of older men. J Bone Miner Res. July 2022;37(7):1213-1220. |
3 |
2 |
| 2022 |
Alajlouni DA, Bliuc D, Tran TS, Blank RD, Cawthon PM, Ensrud KE, Lane NE, Orwoll ES, Cauley JA, Center JR. Muscle strength and physical performance are associated with risk of postfracture mortality but not subsequent fracture in men. J Bone Miner Res. August 2022;37(8):1571-1579. |
0 |
0 |
| 2023 |
Fink HA, Butler ME, Claussen AM, Collins ES, Krohn KM, Taylor BC, Tikabo SS, Vang D, Zerzan NL, Ensrud KE. Performance of fracture risk assessment tools by race and ethnicity: a systematic review for the ASBMR task force on clinical algorithms for fracture risk. J Bone Miner Res. December 2023;38(12):1731-1741. |
0 |
0 |
| 2005 |
Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. May 2005;90(5):2787-2793. |
49 |
45 |
| 1993 |
Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palmero L, Scott J, Vogt TM; Study of Osteoporotic Fractures Research Group. Bone density at various sites for prediction of hip fractures. Lancet. January 9, 1993;341(8837):72-75. |
110 |
92 |
| 1996 |
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. December 7, 1996;348(9041):1535-1541. |
171 |
137 |
| 1995 |
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM; Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women. NEJM. March 23, 1995;332(12):767-773. |
118 |
105 |
| 2003 |
Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. NEJM. September 25, 2003;349(13):1207-1215. |
53 |
47 |
| 2005 |
Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ; PaTH Study Investigators. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. NEJM. August 11, 2005;353(6):555-565. |
34 |
26 |
| 2000 |
Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. August 2000;11(7):556-561. |
45 |
43 |